JPH0244806B2 - BITAMINAOANTEINIHAIGOSHITANYUKAKEIHIFUGAIYOZAISOSEIBUTSU - Google Patents
BITAMINAOANTEINIHAIGOSHITANYUKAKEIHIFUGAIYOZAISOSEIBUTSUInfo
- Publication number
- JPH0244806B2 JPH0244806B2 JP14056381A JP14056381A JPH0244806B2 JP H0244806 B2 JPH0244806 B2 JP H0244806B2 JP 14056381 A JP14056381 A JP 14056381A JP 14056381 A JP14056381 A JP 14056381A JP H0244806 B2 JPH0244806 B2 JP H0244806B2
- Authority
- JP
- Japan
- Prior art keywords
- vitamin
- tocopherol
- glyceride
- skin
- emulsion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 35
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 35
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 35
- 235000019155 vitamin A Nutrition 0.000 claims description 35
- 239000011719 vitamin A Substances 0.000 claims description 35
- 229940045997 vitamin a Drugs 0.000 claims description 35
- 239000000203 mixture Substances 0.000 claims description 24
- 239000011732 tocopherol Substances 0.000 claims description 13
- 229930003799 tocopherol Natural products 0.000 claims description 13
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 12
- 238000002360 preparation method Methods 0.000 claims description 12
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 8
- 235000010384 tocopherol Nutrition 0.000 claims description 8
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 8
- 150000004676 glycans Chemical class 0.000 claims description 7
- 229920001282 polysaccharide Polymers 0.000 claims description 7
- 239000005017 polysaccharide Substances 0.000 claims description 7
- 239000010696 ester oil Substances 0.000 claims description 6
- 125000005456 glyceride group Chemical group 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 3
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 claims description 3
- OBETXYAYXDNJHR-SSDOTTSWSA-M (2r)-2-ethylhexanoate Chemical compound CCCC[C@@H](CC)C([O-])=O OBETXYAYXDNJHR-SSDOTTSWSA-M 0.000 claims description 2
- 229940071106 ethylenediaminetetraacetate Drugs 0.000 claims description 2
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 claims description 2
- SHZIWNPUGXLXDT-UHFFFAOYSA-N caproic acid ethyl ester Natural products CCCCCC(=O)OCC SHZIWNPUGXLXDT-UHFFFAOYSA-N 0.000 claims 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 claims 1
- 229940042585 tocopherol acetate Drugs 0.000 claims 1
- 239000000839 emulsion Substances 0.000 description 15
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 14
- VYGQUTWHTHXGQB-UHFFFAOYSA-N Retinol hexadecanoate Natural products CCCCCCCCCCCCCCCC(=O)OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-UHFFFAOYSA-N 0.000 description 7
- 239000003963 antioxidant agent Substances 0.000 description 7
- 235000006708 antioxidants Nutrition 0.000 description 7
- 238000004040 coloring Methods 0.000 description 7
- 229940108325 retinyl palmitate Drugs 0.000 description 7
- 235000019172 retinyl palmitate Nutrition 0.000 description 7
- 239000011769 retinyl palmitate Substances 0.000 description 7
- 229960001295 tocopherol Drugs 0.000 description 7
- 239000003205 fragrance Substances 0.000 description 5
- 230000003647 oxidation Effects 0.000 description 5
- 238000007254 oxidation reaction Methods 0.000 description 5
- 239000012488 sample solution Substances 0.000 description 5
- 235000019149 tocopherols Nutrition 0.000 description 5
- QUEDXNHFTDJVIY-UHFFFAOYSA-N γ-tocopherol Chemical class OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-UHFFFAOYSA-N 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- -1 but on the contrary Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 230000006641 stabilisation Effects 0.000 description 3
- 238000011105 stabilization Methods 0.000 description 3
- 230000000087 stabilizing effect Effects 0.000 description 3
- 239000012086 standard solution Substances 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- UXTMROKLAAOEQO-UHFFFAOYSA-N chloroform;ethanol Chemical compound CCO.ClC(Cl)Cl UXTMROKLAAOEQO-UHFFFAOYSA-N 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- GZIFEOYASATJEH-VHFRWLAGSA-N δ-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 GZIFEOYASATJEH-VHFRWLAGSA-N 0.000 description 2
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- LXAHHHIGZXPRKQ-UHFFFAOYSA-N 5-fluoro-2-methylpyridine Chemical compound CC1=CC=C(F)C=N1 LXAHHHIGZXPRKQ-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- GZIFEOYASATJEH-UHFFFAOYSA-N D-delta tocopherol Natural products OC1=CC(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 GZIFEOYASATJEH-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- QZKRHPLGUJDVAR-UHFFFAOYSA-K EDTA trisodium salt Chemical compound [Na+].[Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O QZKRHPLGUJDVAR-UHFFFAOYSA-K 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000008294 cold cream Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000010389 delta-tocopherol Nutrition 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- SLCVBVWXLSEKPL-UHFFFAOYSA-N neopentyl glycol Chemical compound OCC(C)(C)CO SLCVBVWXLSEKPL-UHFFFAOYSA-N 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 229960000342 retinol acetate Drugs 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- 239000011770 retinyl acetate Substances 0.000 description 1
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000002446 δ-tocopherol Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/522—Antioxidants; Radical scavengers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Description
本発明はビタミンAを安定に配合した乳化系皮
膚外用剤組成物、さらに詳しくは、ビタミンAを
安定に配合したクリーム、乳液のような皮膚外用
の乳化系医薬製剤、医薬部外品および化粧品に関
する。
従来から、皮膚外用剤の有効成分として各種の
ビタミン類が用いられており、ビタミンAも皮膚
角化症等の予防、治療に有効な成分であることが
知られている。一方、脂溶性ビタミンであるビタ
ミンAは水の非存在下では比較的安定であるが、
水の存在下ではきわめて酸化されやすく、非常に
不安定であることが知られている。
かくして、従来から、乳化系の皮膚外用剤にも
ビタミンAが配合されているが、そのビタミンA
は系中に存在する水のためにきわめて不安定であ
り、経時と共に速やかに酸化されてその効力を失
い、系中に長期にわたつてビタミンAを安定に保
持することが困難である。しかし、かかる乳化系
におけるビタミンAの安定化について、従来、あ
まり検討がなされておらず、未だ乳化系の皮膚外
用剤においてビタミンAを安定に配合できる有効
な手段は見当たらない。
なお、キサンタンガムのような高分子多糖類を
配合してビタミンAの乳化系における安定化を計
ることが提案されているが(特開昭50−82223
号)、高分子多糖類の配合による製品の使用感に
及ぼす影響が問題となる。
このような事情にかんがみ、本発明者は高分子
多糖類を配合しない乳化系の皮膚外用剤における
ビタミンAの安定化について鋭意検討を重ねた。
まず、ビタミンAの配合方法により安定化を図
るべく種々検討したが、安定性の向上は見られな
かつた。つぎに、ビタミンAの酸化を防ぐべく、
各種の抗酸化剤の使用、また、抗酸化剤と、その
シネルギストとして知られるウルトラリン酸、ク
エン酸、アスコルビン酸、ソルビツト、各種アミ
ノ酸との併用を試みたが、かえつて、ビタミンA
の酸化生成物や抗酸化剤、シネルギスト自体に由
来すると考えられる系の著しい着色が生じ、やは
り、充分満足すべき安定性の向上は見られなかつ
た。ところが、意外にも、抗酸化剤としてトコフ
エロールを用いる場合、エチレンジアミン四酢酸
塩(以下、EDTA塩という)および特定の液状
エステル油を併用するとビタミンAの安定性が著
しく向上し、かつ、系の着色という問題も生じな
いことが判明した。
本発明はかかる知見に基づいて完成されたもの
であつて、高分子多糖類を配合しないビタミンA
を有効成分とする乳化系皮膚外用剤組成物におい
て、トコフエロールおよびEDTA塩と、トリカ
プリル酸グリセリド、トリ(2−エチルヘキサン
酸)グリセリド、2−エチルヘキサン酸セチルお
よびジ−(2−エチルヘキサン酸)ネオペンチル
グリコールからなる群から選ばれるエステル油を
配合したことを特徴とするビタミンAを安定に配
合した高分子多糖類無配合乳化系皮膚外用剤組成
物を提供するものである。本発明においては、
EDTA塩も一種の抗酸化剤のシネルギストと考
えられるが、その作用機序は明らかではなく、前
記のごとき従来汎用されるシネルギストと異な
り、系の着色などの問題を生せず、トコフエロー
ルと共にビタミンAの酸化を効果的に防止し、乳
化系の皮膚外用剤に配合されたビタミンAの長期
安定化を図ることができる。
つぎに、乳液に配合したビタミンAに対する各
種のトコフエロール、シネルギストの安定化効果
を試験した結果を示す。
試験方法
後記の処方に従い、ビタミンAパルミテートお
よび各種のトコフエロールおよび/またはシネル
ギストを配合した種々の乳液を調整し、40℃で1
ケ月保存後、各乳液中のビタミンA単位数を定量
し、配合当初のビタミンA単位数に対する残存率
(%)を算出した。また、同時に乳液の着色度合
を肉眼で評価した。
The present invention relates to emulsified external skin preparation compositions containing vitamin A in a stable manner, and more particularly to emulsified pharmaceutical preparations for external use on the skin such as creams and emulsions, quasi-drugs, and cosmetics containing vitamin A in a stable manner. . Conventionally, various vitamins have been used as active ingredients in external skin preparations, and vitamin A is also known to be an effective ingredient in the prevention and treatment of skin keratosis and the like. On the other hand, vitamin A, which is a fat-soluble vitamin, is relatively stable in the absence of water;
It is known to be extremely susceptible to oxidation and extremely unstable in the presence of water. Therefore, vitamin A has traditionally been included in emulsified skin preparations;
Vitamin A is extremely unstable due to the water present in the system, and rapidly oxidizes and loses its effectiveness over time, making it difficult to stably maintain vitamin A in the system over a long period of time. However, the stabilization of vitamin A in such an emulsion system has not been studied much in the past, and no effective means for stably incorporating vitamin A into an emulsion-based skin preparation for external use has yet been found. It has been proposed to stabilize vitamin A in the emulsification system by blending a high-molecular polysaccharide such as xanthan gum (Japanese Patent Laid-Open No. 50-82223).
(No.), the effect of the combination of high-molecular polysaccharides on the feel of the product is a problem. In view of these circumstances, the present inventors have conducted extensive studies on stabilizing vitamin A in emulsified external skin preparations that do not contain polymeric polysaccharides. First, various studies were conducted to stabilize the product by changing the method of blending vitamin A, but no improvement in stability was observed. Next, in order to prevent the oxidation of vitamin A,
We have tried using various antioxidants and combining antioxidants with synergists such as ultraphosphoric acid, citric acid, ascorbic acid, sorbitol, and various amino acids, but on the contrary, vitamin A
Significant coloring of the system occurred, which was thought to be due to the oxidation products of the compound, the antioxidant, and the synergist itself, and no sufficiently satisfactory improvement in stability was observed. However, surprisingly, when using tocopherol as an antioxidant, the stability of vitamin A is significantly improved when ethylenediaminetetraacetate (hereinafter referred to as EDTA salt) and a specific liquid ester oil are used together, and the coloring of the system is significantly improved. It turns out that this problem does not arise. The present invention has been completed based on this knowledge, and provides vitamin A that does not contain polymeric polysaccharides.
In the emulsified skin external preparation composition containing as active ingredients, tocopherol and EDTA salt, tricaprylic acid glyceride, tri(2-ethylhexanoic acid) glyceride, cetyl 2-ethylhexanoate, and di-(2-ethylhexanoic acid) To provide an emulsified skin external preparation composition that is stably blended with vitamin A and is free of polymeric polysaccharides, characterized in that it contains an ester oil selected from the group consisting of neopentyl glycol. In the present invention,
EDTA salt is also considered to be a type of antioxidant synergist, but its mechanism of action is not clear.Unlike the conventionally used synergists mentioned above, it does not cause problems such as coloring of the system, and it is effective against vitamin A along with tocopherol. It is possible to effectively prevent the oxidation of vitamin A and achieve long-term stabilization of vitamin A contained in emulsified skin preparations. Next, the results of testing the stabilizing effects of various tocopherols and synergists on vitamin A blended into emulsion are shown. Test method Various emulsions containing vitamin A palmitate and various tocopherols and/or sinergists were prepared according to the formulations below, and the emulsions were heated at 40℃ for 1
After storage for several months, the number of vitamin A units in each emulsion was determined, and the residual rate (%) relative to the initial number of vitamin A units was calculated. At the same time, the degree of coloring of the emulsion was visually evaluated.
【表】
水 〓 残部
香料 適量
この処方に従い、Aの各成分を混合し、約75℃
で加温溶解し、これを、約75℃に加温したBの各
成分混合物に加え、よく撹拌し、冷却し、ついで
香料を加えて乳液を得た。
ビタミンAパルミテートの定量はつぎのとおり
行なつた。
乳液試料約10gを精秤し、クロロホルム−エタ
ノール(1:1)混液約80mlに溶解した。これを
濾過し、同じ混液で希釈して100mlとし、試料溶
液として用いた。
別途、あらかじめビタミンA単位数を測定した
ビタミンAパルミテート標準品約10mgを精秤し、
クロロホロム−エタノール(1:1)混液で100
mlとし、これを標準溶液として用いた。
これらの試料溶液および標準溶液を、各々、
20μのループ式計量管に注入し、高速液体クロ
マトグラフイーに付した(島津製作所製、高速液
体クロマト装置LC−1、カラム:ヌクレオシル
C−18(28cm×φ4mm)、移動相:メタノール、カ
ラム温度:35℃、流速:1.0ml/分、検出波長:
320nm)。得られたクロマトグラム中のビタミン
Aパルミテートのピーク高さを測定し、試料溶液
のピーク高さをAt、標準溶液のピーク高さをAs
とし、次式に従つて試料溶液中のビタミンA単位
数を求めた。
試料溶液中のビタミン単位数=ビタミンAパルミテート
標準品1gの単位数
×ビタミンAパルミテート標準品秤取量mg×1/1000
×At/As
結果をつぎの第1表に示す。なお、対照として
トコフエロール、シネルギスト無添加の乳液につ
いて同様に試験した結果も示す。また、第1表中
における着色はつぎの基準に従つて評価した。
○:着色なし
△:やや着色気味
×:着色
××:ややひどい着色
×××:ひどい着色
××××:非常に着色[Table] Water = Remainder
Fragrance (appropriate amount)
According to this recipe, mix each component of A at about 75℃.
This was added to the mixture of each component of B heated to about 75°C, stirred well, cooled, and then a fragrance was added to obtain a milky lotion. Quantification of vitamin A palmitate was carried out as follows. Approximately 10 g of the emulsion sample was accurately weighed and dissolved in approximately 80 ml of a chloroform-ethanol (1:1) mixture. This was filtered, diluted with the same mixture to make 100 ml, and used as a sample solution. Separately, accurately weigh out approximately 10 mg of a standard vitamin A palmitate product whose number of vitamin A units has been measured in advance.
100 with chloroform-ethanol (1:1) mixture
ml, and this was used as a standard solution. These sample solutions and standard solutions, respectively,
It was injected into a 20 μ loop measuring tube and subjected to high performance liquid chromatography (Shimadzu Corporation, high performance liquid chromatography device LC-1, column: Nucleosil C-18 (28 cm x φ4 mm), mobile phase: methanol, column temperature. : 35℃, flow rate: 1.0ml/min, detection wavelength:
320nm). Measure the peak height of vitamin A palmitate in the obtained chromatogram, and define the peak height of the sample solution as At and the peak height of the standard solution as As.
The number of vitamin A units in the sample solution was determined according to the following formula. Number of vitamin units in the sample solution = Number of units in 1 g of vitamin A palmitate standard product × Weighed amount of vitamin A palmitate standard product mg × 1/1000
×At/As The results are shown in Table 1 below. In addition, as a control, the results of a similar test on an emulsion without tocopherol or synergist are also shown. Moreover, the coloring in Table 1 was evaluated according to the following criteria. ○: Not colored △: Slightly colored ×: Colored ××: Slightly colored ×××: Severely colored ××××: Very colored
【表】【table】
【表】
第1表に示すごとく、EDTA塩とトコフエロ
ールを併用した場合のみ、40℃、1ケ月の保存の
後にも着色を起すことなく、70%以上もの高いビ
タミンA残存率を保持することができる。
また、前記の乳液処方に天然ビタミンEもしく
はδ−トコフエロール0.05%、EDTA・2Na0.02
%を配合し、かつ、イソプロピルミリステート
1.0%の代わりに、種々の油脂成分を加えて調製
した乳液のビタミンA残存率(%)および着色を
同様に評価した。結果を第2表および第3表に示
す。[Table] As shown in Table 1, only when EDTA salt and tocopherol are used together, a high vitamin A residual rate of over 70% can be maintained without coloring even after storage at 40℃ for one month. can. In addition, the above emulsion formula contains natural vitamin E or δ-tocopherol 0.05%, EDTA/2Na 0.02
% and isopropyl myristate
The vitamin A residual rate (%) and coloring of emulsions prepared by adding various oil and fat components instead of 1.0% were similarly evaluated. The results are shown in Tables 2 and 3.
【表】【table】
【表】【table】
【表】【table】
【表】
第2表および第3表に示すごとく、前記のエス
テル油を併用すると、ビタミンAが著しく安定化
される。
かくして、本発明の皮膚外用剤組成物はO/W
型、W/O型いずれの乳化系でもよく、有効成分
としてビタミンAを配合し、トコフエロールおよ
びEDTA塩の併用および該エステル油の油相へ
の配合によりその安定化を図るものである。
用いるビタミンAとしては、ビタミンAパルミ
テート、ビタミンAアセテート等、通常のこの種
組成物に配合されるものいずれでもよく、配合量
は実際の組成物の剤形、所望の薬効等により適宜
選択できるが、一般に、組成物全量に対して0.01
〜0.5%(重量%、以下同じ)程度が好ましい。
トコフエロールには種々の異性体であるが、本
発明においては特に限定するものではなく、d、
l、dl−体いずれでもよく、また、α、β、γ、
δ−体いずれでもよい。さらに、これらの混合物
やトコフエロールの混合物として知られるビタミ
ンEなども用いることができる。なお、トコフエ
ロールと他の抗酸化剤を組合せると、かえつて酸
化を促進するので、そのような抗酸化剤の混合使
用はさけるべきである。トコフエロールの配合量
も適宜選択できるが、一般に、組成物全量に対し
て0.001〜0.5%程度が望ましい。
EDTA塩としては、EDTA−1ナトリウム、
EDTA−2ナトリウム、EDTA−3ナトリウム、
EDTA−4ナトリウムなどが用いられ、通常、
組成物全量に対して0.001〜0.5%程度が望まし
い。
該エステル油は通常、20%程度までの量で用い
られ、これより多量に用いてもよいが、前記第2
表および第3表から明らかなごとく、それ以上の
ビタミンAの安定化効果の向上は期待できない。
本発明の皮膚外用剤組成物は、常法に従つて、
乳液、クリーム、エアゾール、パツクのような乳
化系の剤形の医薬製剤、医薬部外品、化粧品に調
製することができ、他の配合成分は特に限定する
ものではなく、通常用いられるものいずれでもよ
い。
つぎに実施例を挙げて本発明をさらに詳しく説
明する。
実施例 1[Table] As shown in Tables 2 and 3, when the above-mentioned ester oil is used in combination, vitamin A is significantly stabilized. Thus, the skin external preparation composition of the present invention is O/W.
Either type or W/O type emulsification system may be used, and vitamin A is blended as an active ingredient, and stabilization is attempted by combining tocopherol and EDTA salt and blending the ester oil into the oil phase. The vitamin A to be used may be any of those commonly incorporated into this type of composition, such as vitamin A palmitate and vitamin A acetate, and the amount to be added can be selected as appropriate depending on the actual dosage form of the composition, desired medicinal efficacy, etc. , generally 0.01 based on the total composition
It is preferably about 0.5% (weight %, the same applies hereinafter). There are various isomers of tocopherols, but in the present invention, they are not particularly limited, and include d,
Either l or dl-forms may be used, and α, β, γ,
Any δ-isomer may be used. Furthermore, mixtures of these and vitamin E, which is known as a mixture of tocopherols, can also be used. Note that combining tocopherols with other antioxidants will actually promote oxidation, so mixed use of such antioxidants should be avoided. Although the amount of tocopherol to be added can be selected as appropriate, it is generally desired to be about 0.001 to 0.5% based on the total amount of the composition. EDTA salts include EDTA-1 sodium,
EDTA-disodium, EDTA-trisodium,
EDTA-4 sodium etc. are used, and usually
It is preferably about 0.001 to 0.5% based on the total amount of the composition. The ester oil is usually used in an amount up to about 20%, and may be used in a larger amount, but the second
As is clear from the table and Table 3, no further improvement in the stabilizing effect of vitamin A can be expected. The skin external preparation composition of the present invention can be prepared according to a conventional method.
It can be prepared into pharmaceutical preparations, quasi-drugs, and cosmetics in the form of emulsions such as emulsions, creams, aerosols, and packs, and other ingredients are not particularly limited, and any commonly used ingredients can be used. good. Next, the present invention will be explained in more detail with reference to Examples. Example 1
【表】
香料 適量
この処方に従い、Aの各成分を混合し、約75℃
で加温溶解し、これを、約75℃に加温したBの各
成分混合物に加え、よく撹拌し、冷却し、ついで
香料を加えてビタミンAを安定に配合した乳液を
得た。
実施例 2[Table] Appropriate amount of fragrance
According to this recipe, mix each component of A at about 75℃.
This was added to the mixture of each component of B heated to about 75° C., stirred well, cooled, and then a fragrance was added to obtain an emulsion in which vitamin A was stably blended. Example 2
【表】
香料 適量
この処方に従い、前記実施例1と同様にしてビ
タミンAを安定に配合したコールドクリームを得
た。[Table] Appropriate amount of fragrance
According to this formulation, a cold cream stably containing vitamin A was obtained in the same manner as in Example 1 above.
Claims (1)
化系皮膚外用剤組成物において、トコフエロール
およびエチレンジアミン四酢酸塩と、トリカプリ
ル酸グリセリド、トリ(2−エチルヘキサン酸)
グリセリド、2−エチルヘキサン酸セチルおよび
ジ−(2−エチルヘキサン酸)ネオペンチルグリ
コールからなる群から選ばれるエステル油を配合
したことを特徴とするビタミンAを安定に配合し
た高分子多糖類無配合乳化系皮膚外用剤組成物。1. In a vitamin A-containing external skin preparation composition containing no polymeric polysaccharide, tocopherol and ethylenediaminetetraacetate, tricaprylic acid glyceride, tri(2-ethylhexanoic acid)
Contains an ester oil selected from the group consisting of glyceride, cetyl 2-ethylhexanoate, and neopentyl di-(2-ethylhexanoate) Glyceride Stable blend of vitamin A, free of polymeric polysaccharides Emulsified skin external preparation composition.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP14056381A JPH0244806B2 (en) | 1981-09-07 | 1981-09-07 | BITAMINAOANTEINIHAIGOSHITANYUKAKEIHIFUGAIYOZAISOSEIBUTSU |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP14056381A JPH0244806B2 (en) | 1981-09-07 | 1981-09-07 | BITAMINAOANTEINIHAIGOSHITANYUKAKEIHIFUGAIYOZAISOSEIBUTSU |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5841813A JPS5841813A (en) | 1983-03-11 |
JPH0244806B2 true JPH0244806B2 (en) | 1990-10-05 |
Family
ID=15271586
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP14056381A Expired - Lifetime JPH0244806B2 (en) | 1981-09-07 | 1981-09-07 | BITAMINAOANTEINIHAIGOSHITANYUKAKEIHIFUGAIYOZAISOSEIBUTSU |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH0244806B2 (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60246306A (en) * | 1984-05-22 | 1985-12-06 | Shiseido Co Ltd | Water-in-oil type emulsified cosmetic |
JPS60246307A (en) * | 1984-05-22 | 1985-12-06 | Shiseido Co Ltd | Oil-in-water type emulsified cosmetic |
CA1282326C (en) * | 1984-12-14 | 1991-04-02 | Paul J. Jarosz | Pharmaceutical composition containing 13-cis vitamin a acid as the active ingredient |
US5583136A (en) * | 1990-01-29 | 1996-12-10 | Johnson & Johnson Consumer Products, Inc. | Retinoid containing skin care compositions containing imidazoles |
US5559149A (en) * | 1990-01-29 | 1996-09-24 | Johnson & Johnson Consumer Products, Inc. | Skin care compositions containing retinoids |
KR100295030B1 (en) * | 1992-07-13 | 2001-09-17 | 겜마 아키라 | Skin external composition |
US6461622B2 (en) | 1994-09-07 | 2002-10-08 | Johnson & Johnson Consumer Companies, Inc. | Topical compositions |
JPH1053515A (en) * | 1996-08-09 | 1998-02-24 | Ajinomoto Co Inc | Skin lotion |
US6531141B1 (en) | 2000-03-07 | 2003-03-11 | Ortho-Mcneil Pharmaceutical, Inc. | Oil-in-water emulsion containing tretinoin |
JP5108178B2 (en) * | 2001-02-16 | 2012-12-26 | 花王株式会社 | Packaged product and adsorption prevention method |
JP4119296B2 (en) * | 2003-04-14 | 2008-07-16 | 株式会社コーセー | Cosmetics |
US20050042306A1 (en) * | 2003-08-21 | 2005-02-24 | Christopher Marrs | Stabilized compositions containing an oxygen-labile active agent |
JP5044106B2 (en) * | 2005-05-20 | 2012-10-10 | Basfジャパン株式会社 | Aerosol composition for human body containing vitamins |
JP5902410B2 (en) * | 2010-07-16 | 2016-04-13 | ロート製薬株式会社 | Composition for external use |
-
1981
- 1981-09-07 JP JP14056381A patent/JPH0244806B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JPS5841813A (en) | 1983-03-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR930007911B1 (en) | External preparations free of discoloration | |
KR100309399B1 (en) | Preparation for epidermis | |
US5023235A (en) | Antioxidant system based on an ascorbyl ester in combination with a complexing agent and a thiol and to compositions containing the same | |
US4818521A (en) | Emulsion cosmetic stably containing vitamin C | |
JP3103430B2 (en) | Fat-soluble antioxidant mixture | |
US5114716A (en) | Anti-oxidant system containing stabilized ascorbyl ester, tocopherol or cafeic acid or a derivative thereof, a complexing agent and a polypeptide, and compositions containing the anti-oxidant system | |
ES2212344T3 (en) | STABLE COMPOSITIONS CONTAINING BIOLOGICALLY ACTIVE COMPONENTS. | |
JPH0244806B2 (en) | BITAMINAOANTEINIHAIGOSHITANYUKAKEIHIFUGAIYOZAISOSEIBUTSU | |
JPH05271048A (en) | Cosmetics and pharmaceutical composition | |
JPH0751491B2 (en) | Emulsified cosmetics containing crude drugs | |
US6124274A (en) | Use of ascorbyl 2'-phosphates for stabilizing vitamin A and/or vitamin A derivatives in cosmetic and pharmaceutical preparations | |
JP2822093B2 (en) | W / O / W type emulsified cosmetic | |
KR100297347B1 (en) | A W/O type emulsion cosmetic composition containing the stabilized L-ascorbic acid and a method for preparing the same | |
JPS61130232A (en) | Shikonin-containing composition | |
JPS6245202B2 (en) | ||
JP2663136B2 (en) | Whitening cosmetics | |
JPH11335284A (en) | Retinoid-containing skin lotion | |
US5250513A (en) | Antioxidant system based on a basic amino acid in combination with a tocopherol or derivative thereof and a nonthiolated polypeptide, and compositions containing the same | |
JPS6256411A (en) | Beautifying agent | |
US5378453A (en) | Composition for preventing graying of the hair and restoring grayed hair to its natural color | |
JPH1017436A (en) | Skin preparation for external use | |
CN114828839B (en) | Vitamin A and vitamin C combinations with enhanced stability | |
JP2906269B2 (en) | External preparation for skin | |
JP3421071B2 (en) | External preparation containing oil-soluble licorice extract | |
KR100416281B1 (en) | Novel emulsion compositions of cosmetics, drugs and foods with excellent stability against oxidation |